Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$10.66 -1.39%
Market Cap
$53.1M
Price Target
Refer to Report
Volume
25.3K
52wk Range
$8.4801 - $30.64
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.